Spectrum Pharma

SPPI NASDAQ
7.88
+0.02
+0.25%
After Hours: 7.88 0 0.00% 17:53 07/17 EDT
Open
7.86
Prev Close
7.86
High
7.99
Low
7.76
Volume
526.21K
Avg Vol (3M)
789.26K
52 Week High
25.29
52 Week Low
6.22
% Turnover
0.47%
Market Cap
882.27M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Spectrum Pharma SPPI stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company operates through developing and commercializing oncology and hematology drug products segment. It focuses on developing ROLONTIS and POZIOTINIB. ROLONTIS is being investigated for the treatment of chemotherapy-induced neutropenia. POZIOTINIB is an oral pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR, HER) Family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations.
MORE >

Recently

Name
Price
%Change